Page last updated: 2024-08-18

phenformin and Angiogenesis, Pathologic

phenformin has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albini, A; Bertolini, F; Calleri, A; Dallaglio, K; Gregato, G; Labanca, V; Mancuso, P; Noonan, DM; Orecchioni, S; Reggiani, F; Talarico, G	1

Other Studies

1 other study(ies) available for phenformin and Angiogenesis, Pathologic

Article	Year
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells. International journal of cancer, 2015, Mar-15, Volume: 136, Issue:6 Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Electron Transport Complex I; Female; Humans; Metformin; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Phenformin; Phosphorylation; TOR Serine-Threonine Kinases; Tumor Microenvironment	2015

Article

Year

The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.

International journal of cancer, 2015, Mar-15, Volume: 136, Issue:6

Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Electron Transport Complex I; Female; Humans; Metformin; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Phenformin; Phosphorylation; TOR Serine-Threonine Kinases; Tumor Microenvironment

2015